Estimated effects of the national breast and cervical cancer early detection program on breast cancer mortality

American Journal of Preventive Medicine

Volumn 40, Issue 4, 2011, Pages 397-404

  Hoerger, Thomas J ^a   Ekwueme, Donatus U ^b   Miller, Jacqueline W ^b   Uzunangelov, Vladislav ^a   Hall, Ingrid J ^b   Segel, Joel ^a   Royalty, Janet ^b   Gardner, James G ^b   Smith, Judith Lee ^b   Li, Chunyu ^b  

^a RTI INTERNATIONAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MEASLES VACCINE; RUBELLA VACCINE; TAMOXIFEN;

ADULT; ARTICLE; BARIUM ENEMA; BLOOD EXAMINATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ASSESSMENT; COLONOSCOPY; EARLY DIAGNOSIS; FEMALE; HUMAN; INVASIVE CARCINOMA; LIFESPAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM; OCCULT BLOOD; PAPANICOLAOU TEST; PROBABILITY; SENSITIVITY ANALYSIS; SIMULATION; SMOKING CESSATION; SURVIVAL TIME; TUMOR VOLUME; UTERINE CERVIX CANCER; VACCINATION;

ADULT; BREAST NEOPLASMS; COMPUTER SIMULATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MEDICALLY UNINSURED; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; POVERTY; UNITED STATES;

EID: 79952539930     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2010.12.017     Document Type: Article

References (29)

1. U.S. Cancer Statistics Working Group. U.S. Cancer Statistics: 2005 Incidence and Mortality. Atlanta GA: USDHHS, CDC and National Cancer Institute, 2010. www.cdc.gov/uscs.
2. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009;151:738-47.
3. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:347-60.
4. U.S. Preventive Services Task Force (USPSTF). Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002;137: 344-46.
5. Berry DA, Cronin KA, Plevritis SK, et al. Effects of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92. (Pubitemid 41549890)
6. Mandelblatt JS, Yabroff KR. Effectiveness of interventions designed to increase mammography use: a meta-analysis of provider-targeted strategies. Cancer Epidemiol Biomarkers Prev 1999;8:759-67. (Pubitemid 29445012)
7. Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 2003;348:1672-80. (Pubitemid 36459474)
8. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials [published erratum appears in Lancet 2002;360(9334):724]. Lancet 2002;359(9310):909-19.
9. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials 1993 Feb 25; Doc No. 32: 23,227 words.
10. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;54:141-69.
11. Feig SA, Kopans DB, Sickles EA, Jackson VP, Monsees B. Rationale for annual screening mammography for women ages 40-49 years. Breast Dis 1998;10(3-4):13-21. (Pubitemid 28470199)
12. Nelso HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-37.
13. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-26.
14. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
15. CDC. National Breast and Cervical Cancer Early Detection Program. www.cdc.gov/cancer/nbccedp/about.htm.
16. Eheman CR, Benard VB, Blackman D, et al. Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (U.S.). Cancer Causes Control 2006;17:29-38.
17. Cronin KA, Yu B, Krapcho M, et al. Modeling the dissemination of mammography in the U.S. Cancer Causes Control 2005;(16):701-12.
18. Plevritis SK, Salzman P, Sigal BM, Glynn P. A natural history model of stage progression applied to breast cancer. Stat Med 2007;(26):581-95. (Pubitemid 46139540)
19. Plevritis SK, Sigal BM, Salzman P, Rosenberg J, Glynn P. Chapter 12. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000. J Natl Cancer Inst Monogr 2006;(36):86-95.
20. Feuer EJ. Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem. J Natl Cancer Inst Monogr 2006;(36):2-6.
21. Holford TR, Cronin KA, Mariotto AB, Feuer EJ. Chapter 4. Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr 2006;(36):19-25.
22. Cronin KA, Mariotto AB, Clarke LD, Feuer EJ. Chapter 5. Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality. J Natl Cancer Inst Monogr 2006;(36): 26-9.
23. Rosenberg M. Chapter 3. Competing risks to breast cancer mortality. J Natl Cancer Inst Monogr 2006;(36):15-9.
24. USDHHS. Healthy People 2010: understanding and improving health. 2nd ed. Washington DC: U.S. Government Printing Office, 2003.
25. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions - standardizing data on outcomes. N Engl J Med 1998;339:380-6. (Pubitemid 28363802)
26. Howard DH, Ekwueme DU, Gardner JG, Tangka FL, Li C, Miller JW. The impact of a national program to provide free mammograms to low-income, uninsured women on breast cancer mortality rates. Cancer 2010;116(19):4456-62.
27. Tengs TO. Cost-effectiveness versus cost-utility analysis of interventions for cancer: does adjusting for health-related quality of life really matter? Value Health 2004;7(1):70-8.
28. CDC. WISEWOMAN: Well-Integrated Screening and Evaluation for Women Across the Nation. www.cdc.gov/WISEWOMAN/.
29. Tangka FKL, Dalaker J, Chattopadhyay SK, et al. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (U.S.). Cancer Causes Control 2006;17:1145-54.